You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Ashland guided fiscal 2027 sales of $1.905 billion to $1.975 billion and adjusted EBITDA of $405 million to $435 million, after fourth-quarter sales rose 4% to $498 million and adjusted EBITDA rose 2% to $121 million.
Ashland Inc. reported preliminary fiscal 2026 sales of $1.863 billion and Adjusted EBITDA of $385 million, then guided fiscal 2027 sales to $1,905 million to $1,975 million and Adjusted EBITDA to $405 million to $435 million.
Ashland Inc. amended its European accounts receivable securitization program on September 24, 2026, extending the facility’s scheduled termination date to September 21, 2029; the revolving facility retains an aggregate limit of €125 million.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ASH
this stock
Ashland Inc.
|
$3.50B | +30.3% | -13.7% | — | 11.1% |
|
LIN
Linde PLC
|
$241.51B | +23.4% | +3.0% | 34.9 | 1.4% |
|
AIQUF
L Air Liquide SA
|
$137.11B | +14.4% | — | — | 0.0% |
|
ECL
Ecolab Inc.
|
$86.74B | +17.8% | +2.2% | 42.1 | 1.5% |
|
SHW
Sherwin Williams Co
|
$84.53B | +8.0% | +2.1% | 32.2 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Ashland Inc. reported preliminary fiscal 2026 sales of $1.863 billion and Adjusted EBITDA of $385 million, then guided fiscal 2027 sales to $1,905 million to $1,975 million and Adjusted EBITDA to $405 million to $435 million.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ASH | -0.2% | +7.5% | +32.2% | +2.4% | +30.3% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -2.8% | +8.6% | +31.7% | +2.6% | +19.7% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
